Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von CandyButcher 

Merck & Co. Inc. diskutieren

Merck & Co. Inc.

WKN: A0YD8Q / Symbol: MRK / Name: Merck & Co / Aktie / Pharmazeutika / Large Cap /

117,40 €
2,07 %

Einschätzung Buy
Rendite (%) 3,26 %
Kursziel 123,70
Veränderung
Endet am 30.06.27

Merck & Co., Inc. (MRK) had its price target raised by Bank of America Corporation from $130.00 to $141.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,81 %
Kursziel 124,38
Veränderung
Endet am 08.07.27

Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,68 %
Kursziel 127,24
Veränderung
Endet am 13.07.27

Merck & Co., Inc. (MRK) had its price target raised by Guggenheim from $140.00 to $145.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,99 %
Kursziel 124,61
Veränderung
Endet am 13.07.27

Merck & Co., Inc. (MRK) had its price target raised by BMO Capital Markets from $135.00 to $142.00. They now have an "outperform" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,16 %
Kursziel 122,85
Veränderung
Endet am 13.07.27

Merck & Co., Inc. (MRK) had its price target raised by JPMorgan Chase & Co. from $135.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat